Lanfos

250 mg

Generic Name: Lanthanum Carbonate
Strength: 250 mg

Product Description:
Lanfos Chewable Tablet contains Lanthanum Carbonate, a phosphate binder used to reduce serum phosphate levels in patients with chronic kidney disease (CKD), particularly those on dialysis. By binding dietary phosphate in the gastrointestinal tract, it prevents its absorption, helping to maintain normal phosphate levels.

Key Features:

• Each chewable tablet contains Lanthanum Carbonate 250 mg.

• Used for the management of hyperphosphatemia in CKD patients.

• Chewable formulation for easy administration without water.

• Does not contain calcium or aluminum, reducing the risk of calcium overload or aluminum toxicity.

Indications:

• Control of serum phosphate levels in patients with end-stage renal disease.

Dosage & Administration:

• The recommended starting dose is typically 250 mg to 500 mg with meals, adjusted based on phosphate levels.

• Must be chewed thoroughly before swallowing.

Packaging:

• Usually available in blister packs or bottles (confirm pack size from supplier).